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Abstract 
Primary human fetal cells have been used in clinical trials of cell replacement therapy for the 
treatment of neurodegenerative disorders such as Huntington's disease (HD). However, human fetal 
pƌiŵaƌǇ Đells aƌe sĐaƌĐe aŶd difﬁĐult to ǁoƌk ǁith aŶd so a ƌeŶeǁaďle souƌĐe of Đells is sought. 
Human fetal neural stem cells (hfNSCs) can be generated from human fetal tissue, but little is known 
about the differences between hfNSCs obtained from different developmental stages and brain 
areas. In the present work we characterized hfNSCs, grown as neurospheres, obtained from three 
developmental stages: 4–5, 6–7and 8–9 weeks post conception (wpc) and four brain areas: 
forebrain, cortex, whole ganglionic eminence (WGE) and cerebellum. We observed that, as fetal 
brain development proceeds, the number of neural precursors is diminished and post-mitotic cells 
are in-creased. In turn, primary cells obtained from older embryos are more sensitive to the 
dissociation process, their viability is diminished and they present lower proliferation ratios 
compared to younger embryos. However, independently of the developmental stage of derivation 
proliferation ratios were very low in all cases. Improvements in the expansion rates were achieved 
by mechanical, instead of enzymatic, dissociation of neurospheres but not by changes in the seeding 
densities. Regardless of the developmental stage, neurosphere cultures presented large variability in 
the viability and proliferation rates during the initial 3–ϰ passages, ďut staďilized aĐhieǀiŶg sigŶiﬁĐaŶt 
expansion rates at passage 5 to 6. This was true also for all brain regions except cerebellar derived 
cultures that did Ŷot eǆpaŶd. IŶteƌestiŶglǇ, the ďƌaiŶ ƌegioŶ of hfNSC deƌiǀatioŶ iŶﬂueŶĐes the 
expansion potential, being forebrain, cortex and WGE derived cells the most expandable compared 
to cerebellar. Short term expansion partially compromised the regional identity of cortical but not 
WGE cultures. Nevertheless, both expanded cultures were multipotent and kept the ability to 
diffeƌeŶtiate to ƌegioŶ speĐiﬁĐ ŵatuƌe ŶeuƌoŶal pheŶotǇpes. 
 
1. Introduction 
Several clinical trials for both Parkinson's Disease and Huntington's Disease (HD) have demonstrated 
proof-of-principle that cell replaceŵeŶt theƌapǇ ĐaŶ pƌoǀide sigŶiﬁĐaŶt alleǀiatioŶ of sǇŵptoŵs iŶ 
both conditions (Bachoud-Lévi et al., 2006; Kelly et al., 2011; Lindvall et al., 1990; Mendez et al., 
2008). Following transplantation, implanted primary neuroblasts from human fetal origin, can 
mature, innervate the surrounding neuropil, and contribute to the repair of circuitry that has been 
damaged as a result of the degeneration. However, the use of human primary fetal tissue for human 
transplantation carries with it many constraints. First, availability is severely limited, although this 
has been addressed to some extent through collection of medical terminations of pregnancy 
(MTOPs) rather than surgical terminations of pregnancy (STOPs) (Kelly et al., 2011). Despite this, 
variability in developmental stage between fetuses, heterogeneity of fetal samples that need to be 
pooled, very limited capacity for storage, and logistical problems in coordinating patient, surgery and 
tissue collection all mean that a source of cells that is more readily available and more amenable to 
quality control is required. 
Thus a key challenge to the development of cell replacement therapies for neurodegenerative 
diseases is the ideŶtiﬁĐatioŶ of easilǇ expandable multipotent cell sources with the capacity to 
diffeƌeŶtiate iŶto the speĐiﬁĐ tǇpes of ŶeuƌoŶs that haǀe ďeeŶ lost to the disease pƌo-cess. One such 
source could be neural stem cells (NSCs) derived from the human fetal central nervous system (CNS). 
These cells can proliferate to give rise to an expanded and more homogeneous population. One 
teĐhŶiƋue foƌ gƌoǁiŶg NSCs iŶǀolǀes the geŶeƌatioŶ of fƌee ﬂoatiŶg spheƌiĐal aggregates termed 
͚Ŷeuƌospheƌes͛. This ŵethod ǁas deǀeloped for rodent tissues a number of years ago (Ostenfeld et 
al., 2002; Reynolds et al., 1992) and has been also adapted for the long-term growth of human cell 
neurospheres (Carpenter et al., 1999; Ostenfeld et al., 2002; Svendsen et al., 1998; Vescovi et al., 
1999). Neurospheres consist of both multipotent stem cells and more restricted progenitors 
(Ostenfeld et al., 2002; Reynolds and Weiss, 1996) and, as such, are considered to comprise a 
heterogeneous population of neural precursor cells (NPCs) (Bez et al., 2003; Ostenfeld et al., 2002; 
Sun et al., 2011; Suslov et al., 2002). 
However, a detailed characterization of the properties of hfNSCs of different origins and their 
progeny is required before considering application in patients. Currently, the expansion capacity and 
differentiation potential of NSCs isolated from human fetal brain are incompletely understood. 
Several studies have reported region-speĐiﬁĐ diffeƌeŶĐes foƌ hfNSCs eǆpaŶded as Ŷeuƌospheres in 
vitro (Hitoshi et al., 2002; Horiguchi et al., 2004; Kallur et al., 2006; Kim et al., 2006; Ostenfeld et al., 
2002). First, neurospheres from the forebrain grew faster than NSCs obtained from caudal brain 
areas (Horiguchi et al., 2004; Kim et al., 2006), and second, differences in the neurogenic potential 
and the neuronal phenotypes obtained after NSCs differentiation have been described, depending 
on the brain area of origin. In addition, these differences in neuronal differentiation appeared to be 
sustained during long-term passage of neurospheres in culture (Kim et al., 2006). In vivo 
characterization has also been carried out in several studies: hfNSCs have been isolated from the 
whole human fetal forebrain or cortex, expanded in vitro and grafted into the brains of neonatal and 
adult rodents (Burnstein et al., 2004; Caldwell et al., 2001; Englund et al., 2002a, 2002b; Le Belle et 
al., 2004; Svendsen et al., 1998; Tamaki et al., 2002; Uchida et al., 2000; Zietlow et al., 2012; Zietlow 
et al., 2005). However, it is still unclear how much the region of origin, site of implantation and host 
eŶǀiƌoŶŵeŶt iŶﬂueŶĐe the fate of hfNSCs afteƌ iŶtƌaĐeƌeďƌal tƌaŶsplaŶtatioŶ. 
Here, we characterized a representative number of human fetal brain tissue samples derived from 
three developmental stages (4–5, 6–7and8–9 weeks post conception (wpc)) and four brain regions: 
fore-brain, cortex, whole ganglionic eminence (WGE) and cerebellum. All these samples were grown 
in short-term cultures as neurospheres and two main objectives were addressed: 1) the effect of the 
gestational age of the tissue on survival, hfNSC proliferation and gene expression and 2) the effect of 
passage on rates of expansion and differentiation potential, especially the maintenance of regional 
identity. 
2. Materials and methods 
2.1. Human fetal tissue collection 
Human fetal tissue was collected following the guidelines of the Polkinghorne (Polkinghorne J) and 
UK Department of Health reports as previously described (Kelly et al., 2011). Full consent was 
obtained from the maternal donor, following consent through the SWIFT human fetal tissue bank 
(http://www.biobankswales.org.uk/swift-research-tissue-bank), under UK Human Tissue Authority 
research li-cence (no. 12457) held by Cardiff University, and with ethical approval 02/4446 Post 
mortem human fetal tissue for neural transplantation in HD and PD from the Bro Taf research ethics 
committee. Fetal tissue ranged in age from 4 to 10 wpc (Table 1), assessed by ultra sound 
measuƌeŵeŶts aŶd ĐoŶﬁƌŵed usiŶg fetal morphometric data upon termination (Evtouchenko et al., 
1996; Hurelbrink et al., 2000). The age of the fetus was estimated as previously described (Kelly et 
al., 2011). 
2.2. Medical termination of pregnancy (MTOP) 
Human fetal tissue ranging in age from 4 to 10 wpc was collected ac-cording to (Kelly et al., 2011). 
Following expulsion of the products into a disposable cardboard receptacle, fetal material was 
inspected by the nursing staff, before being promptly transferred to a sterile 500-ml pot containing 
HiďeƌŶate E ;Theƌŵo FisĐheƌ SĐieŶtiﬁĐ. Walthaŵ, MA USAͿ, aŶd ǁas stoƌed at ϰ °C ;usuallǇ foƌ up to 
3 h but for a maximum of 12 h) before being transported on ice. The time at which the products of 
conception were passed were recorded. 
2.3. Dissection of human fetal brain tissue 
A total of 23 embryos were collected on the day following MTOP and they were stored as whole 
embryos in Hibernate E overnight at 4 °C. The following morning tissues of interest, Forebrain, 
Whole Ganglionic Eminence (WGE), cortex and cerebellum, were dissected and tissue pieces were 
processed as described below (see Table 1 for summary of the embryos collected and tissues of 
interest dissected). Whole brains were dissected for immunohistochemistry characterization (see 
Section 
Table 1 
Human fetal brain samples included in the characterization study. Summary of brain human fetal 
samples collected and analyzed at different developmental stages and from several brain areas. 
Note that the ideŶtiﬁĐatioŶ of the saŵples iŶĐludes Ϯ oƌ 3 letters (CB for cerebellum, CTX for cortex, 
FB for forebrain, WGE for whole ganglionic eminence and WB for whole brain) and three-four 
numbers that account for each embryo. We also de-scribe gestational and post-conception age 
(weeks (wks) and days) and the crown rump length (CRL) for each sample. 
 2.12). A representative scheme in Supplementary Fig. 1 shows the developmental stages under 
study that were divided in three groups: 4–5, 6–7and 8–9 wpc, different brain regions and the 
parameters analyzed. 
2.4. Preparation of primary fetal brain tissue cell suspension 
Dissected tissue pieces were incubated in 1 ml of TrypLE express (Invitrogen TM Thermo Fischer 
SĐieŶtiﬁĐ, FeƌŵoŶt, USAͿ foƌ ϮϬ ŵiŶ at ϯϳ °C, afteƌ ǁhiĐh DNAse ;Sigŵa-Aldrich Química SL, Madrid, 
Spain, UK, 0.01%) was added, and tissue incubated for a further 5 min at 37 °C. Tissue pieces of 
interest were washed twice with complete mediuŵ ĐoŶtaiŶiŶg: DulďeĐĐo's ŵodiﬁed Eagle's ŵediuŵ 
(DMEM)/F-12, supplemented with 1% Glutamine and 1% PSF antibioticantimycotic (all from 
IŶǀitƌogeŶ TM Theƌŵo FisĐheƌ SĐieŶtiﬁĐͿ, aŶd theŶ ĐolleĐted ďǇ ĐeŶtƌifugatioŶ at ϭϬϬϬ ƌpŵ foƌ ϯ ŵiŶ. 
The tissue ǁas ƌesuspeŶded iŶ ϮϬϬ μl DMEM/FϭϮ, aŶd theŶ tƌituƌated to produce a single cell 
suspension. Then cell viability was determined and cells were plated in suspension cultures for 
eǆpaŶsioŶ as eǆplaiŶed ďeloǁ oƌ ĐolleĐted iŶ ‘NA lateƌ aŶd ĐoŶseƌǀed at −ϴϬ °C foƌ geŶe eǆpƌessioŶ 
analysis. 
2.5. Assessment of cell viability 
Cell suspensions obtained from each fetal brain region of interest or from growing neurospheres 
dissociated cultures were counted in a hemocytometer using the trypan blue exclusion method. The 
proportions of live and dead cells were recorded and viability or % of dead cells expressed as the 
percentage of live or dead cells in the suspension, respectively. 
2.6. Cell culture expansion 
Fetal brain tissue derived neurosphere cultures were obtained by seeding 80.000 cells/cm2 in 
expansion medium containing: complete medium (DMEM/F-12, supplemented with 1% Glutamine 
and 1% PSF antibioticantimycotic) supplemented with 1% N2 supplement (Invitrogen TM Thermo 
FisĐheƌ SĐieŶtiﬁĐͿ, ϮϬ Ŷg/ŵl ‘eĐoŵďiŶaŶt HuŵaŶ ﬁďƌoďlast gƌoǁth faĐtoƌ ďasiĐ ;FGF; ‘&D SǇsteŵs 
Inc. Abingdon, UK) and 20 ng/ml epidermal growth factor (EGF; Sigma-Aldrich Química SL), 0,1% 
Human Leukemia Inhibitory Factor (LIF, Sigma-Al-drich Química SL.) Cells were maintained at 37 °C in 
a huŵidiﬁed atŵosphere with 5% CO2. Expansion culture media was changed every 3–4 days. Every 
7 to 10 days, depending on the size of the neurospheres, they were collected by centrifugation at 
1000 rpm for 3 min, then incubated with 1 ml of Accutase (GE Healthcare Europe GmbH, Barcelona, 
Spain) at 37 °C for 30 min, spun down at 1000 rpm for 3 min and dissoĐiated iŶ ϮϬϬ μl of fƌesh 
Accutase. Single dissociated cells were counted as previously described. Cells were re-plated in fresh 
eǆpaŶsioŶ ŵedia at a deŶsitǇ of ϴϬ.ϬϬϬ Đells/ĐŵϮ iŶ Đultuƌe ﬂasks foƌ ϲ passages. 
A total of six passages (a total of about 8 weeks in culture) were performed for all the cultures that 
expanded properly. This short term passage took into account the work of Zietlow and Collabora-
tors in which they demonstrated that long term passaged human fetal neural progenitors leads to 
reduced graft viability after trans-plantation (Zietlow et al., 2012). At each passage we analyzed 
viabil-ity, differentiation and expansion potential. Gene expression was analyzed at passage 0, 3 and 
6. 
In order to analyze the expansion potential of hfNSC two parameters were calculated: 
- Ratio of Proliferation: total number of dissociated single cells after each passage divided by 
the number initially plated. 
- Number of accumulated cells: an estimate of the number of cells that would be obtained if 
all the cells obtained after each passage were subcultured taking into account the ratios of 
proliferation obtained at each passage for each culture. 
 
2.7. Cell density assay 
Cell density was studied by plating primary fetal brain cells at: 20,000, 40,000, 80,000, 120,000 and 
160,000 cells/cm2 in expansion media for 10 days. Afterwards, neurospheres were collected, 
dissociated and the number of single cells counted. For each cell density we analyzed the ratio of 
proliferation and the viability. Two different develop-mental stages were analyzed: 6–7and 8–9 wpc. 
Results are expressed as the mean of independent experiments ± SEM. Statistical analysis was 
performed by two way ANOVA and Tukey's multiple comparison test for the comparison of cell 
densities for each developmental stage. 
2.8. Mechanical and enzymatic dissociation 
In order to improve the expansion of hfNSC cultures, two splitting methodologies were compared: 
enzymatic dissociation using Accutase as previously described and mechanical dissociation using the 
chopping technique. 
Mechanical dissociation was performed as described: medium was added to the pelleted 
neurospheres after each passage and they were transferred with a Pasteur pipette to a Petri dish. 
Neuƌospheƌes ǁeƌe Đhopped ﬁƌŵlǇ ǁith a steƌile ďlade iŶto ϮϱϬ μŵ pieĐes ;± ϭϬ μŵͿ and transferred 
back to a collecting tube with media. The Petri dish was washed several times with culture media to 
collect all the cells. Sphere pieces were split 1:1 in expansion media. 
For this study, cultures derived from 6 to 7 and from 8 to 9 wpc were passaged using both 
techniques over 6 passages. For viability, the fold change in the number of cells and the number of 
accumulated cells was determined at passage 3 and 6. Fold change was determined as the fold 
change in the number of cells at passage 3 and 6 respect to the number of cells plated initially (at 
passage 0). In order to count the number of cells at passage 3 and 6, 1/10 of the initial neurosphere 
suspension was taken from the bulk and dissociated with accutase following the enzymatic 
dissociation protocol. 
Results are expressed as log transformed individual values and the mean for the fold change 
parameter and square root transformed individual values and the mean for the number of 
accumulated cells. Statistical analysis was performed by one way ANOVA and Tukey's multiple 
comparison test. 
2.9. Neurospheres sections 
Proliferating neurospheres derived from Cortex, Forebrain, WGE and Cerebellum at passage 3 were 
ﬁxed with 4% PFA/PBS for 1 h, cryoprotected with 20% sucrose in PBS, and frozen in dry-ice cooled 
isopeŶtaŶe. SeĐtioŶs ;ϭϬ μŵ thick) were collected on silane coated slides aŶd ĐoŶseƌǀed at −ϮϬ °C. 
Afteƌǁaƌds, theǇ ǁeƌe staiŶed foƌ NestiŶ, Kiϲϳ, β-III-tubulin and GFAP ﬂuoƌesĐeŶĐe iŵŵuŶostaiŶiŶg 
following the protocol described below. 
2.10. Cell culture differentiation 
To assess the differentiation potential along passages, dissociated cells were plated onto 13-mm, 
poly-L-lysine-coated cover- slips (0.1 mg/ml in distilled H2O) at a density of 25.000 cells/cm2. Cells 
were placed in the center of the coverslip iŶ ϯϬ μl of diffeƌeŶtiatioŶ ŵedium (complete medium 
supplemented with 1% fetal calf serum and 2%B27) for 1 h to allow cell attachment. Afterwards, 500 
μl of diffeƌeŶtiation media was added per well and cells were allowed to differentiate for either 7 
days (short-term differentiation) or 21 days (long term differentiation). They were fed by replacing 
half of the medium with fresh one every 3 days. Cells were then washed using PBS and prepared for 
iŵŵuŶoĐǇtoĐheŵistƌǇ ďǇ ﬁǆatioŶ ǁith ϰ% paƌafoƌŵaldehǇde iŶ Ϭ.ϭ M PBS foƌ ϮϬ ŵiŶ. 
Differentiation potential was analyzed for cortical and WGE cultures. 
2.11. Immunocytochemistry 
Fluorescent immunocytochemistry was performed for proliferating neurospheres and differentiated 
cultures at 7 and 21 days in vitro. Standard protocols were used as previously described (Martín-
Ibáñez et al., 2007) with primary antibodies directed against: anti-GFAP (Polyclonal 1:1000, Dako 
Diagnósticos, S.L.U.; Barcelona, Spain), anti-β III TuďuliŶ ;ŵoŶoĐloŶal aŶd polǇĐloŶal ϭ:ϱϬϬ; Sigŵa-
Aldrich Química SL), anti-Ki67 (clone SP6, monoclonal 1:100 Abcam; Cambridge, UK), anti Nestin 
(monoclonal 1:200; Merck Chemicals and Life Science GesmbH; Ma-drid, Spain), anti-DARPP-32 
(polyclonal 1:200; Abcam), anti-tyrosine hydroxylase (TH, polyclonal 1:300; Merck Chemicals and Life 
Science GesmbH), anti-MAP2 (2a + 2b) (Monoclonal 1:200 Sigma-Aldrich Química SL), anti-Ctip2 
(rabbit 1:250; Abcam), anti-Calbindin (D-28K, rabbit 1:10,000, Swant® Swiss antibodies, Marly, 
Switzerland), anti-Calretinin (polyclonal 1:1500, Merck Chemicals and Life Science GesmbH), anti-
Vglut1 (rabbit 1:500, Synaptic Systems, Göttingen, Ger-many). The following secondary antibodies 
were used: Conjugated-Cy3 Donkey anti-Rabbit IgG (H + L) 1:500, Conjugated-Cy3 Donkey anti-
Mouse IgG (H + L) 1:500, Conjugated-488 Donkey anti-Mouse IgG (H + L) 1:500, Conjugated-Alexa-
488 Donkey anti-Rabbit IgG (H + L) 1:500 (all from Jackson Immuno Research Europe Ltd. Suffolk, 
UK). No signal was detected in control preparations from which the primary antibody was omitted. 
Fluorescent photomicrographs were taken on a Leica TCS SL laser scanning confocal spectral 
ŵiĐƌosĐope ;LeiĐa MiĐƌosisteŵas S.L.U. BaƌĐeloŶa, SpaiŶͿ. All iŵages ǁeƌe aĐƋuiƌed as tiff ﬁles aŶd 
adjustments of brightness and contrast were performed with ImageJ software. 
2.12. Immunohistochemistry 
Whole Brains, heads and/or whole human fetuses were frozen in Isopentane (Thermo Fischer 
SĐieŶtiﬁĐͿ oŶ dƌǇ-iĐe aŶd kept at −ϴϬ °C uŶtil seƌial ĐoƌoŶal seĐtioŶs ;ϭϱ μŵͿ ǁeƌe Đut oŶ a ĐƌǇostat 
and collected on silaneĐoated slides aŶd fƌozeŶ at −ϮϬ °C. 
Fetal sections were treated with fresh PFA 4% for 10 min. Then, 3 × 5 min washes with PBS were 
performed and sections were blocked for 1 h in blocking buffer containing: PBS with 0.3% Triton X-
100 and 1%bovine serum albumin (BSA) to avoid non-speĐiﬁĐ ďiŶdiŶg. Afterwards, samples were 
incubated overnight at 4 °C in PBS containing 0.3% Triton X-100 and 1% BSA with the corresponding 
primary antibodies: antinestin (Rat 401; 1:50; polyclonal; Developmental Studies Hybridoma Bank; 
The University of Iowa), anti-Ki6ϳ ;ĐloŶe SPϲ; ϭ:ϭϬϬ; ƌaďďit ŵoŶoĐloŶal; Theƌŵo FisĐheƌ SĐieŶtiﬁĐͿ, 
anti-Doublecortin (DCX; 1:200; polyclonal; Abcam; Cambridge, UK), anti-NeuN (1:100; mono-clonal; 
Merck Chemicals and Life Science GesmbH; Madrid, Spain), anti-Ctip2 (1:200; polyclonal; Abcam). 
After three PBS washes, human fetal sections were incubated for 2 h at room temperature with the 
sec-ondary antibodies (Cy3-conjugated donkey anti-rabbit IgG (1:500), Cy2-conjugated donkey anti-
mouse (1:200); Jackson Immuno Research Europe Ltd.). Human fetal sections were stained with 
Hoesch and mounted in Fluoromount-G (0100-01, SouthernBiotech, Birmingham, USA). No signal 
was detected in control preparations from which the primary antibody was omitted. Fluorescent 
photomicrographs were taken on a Leica TCS SL laser scanning confocal spectral microscope (Leica 
MiĐƌosisteŵas S.L.U. BaƌĐeloŶa, SpaiŶͿ. All iŵages ǁeƌe aĐƋuiƌed as tiff ﬁles aŶd adjustŵeŶts of 
brightness and contrast were performed with ImageJ software. 
2.13. Quantitative PCR assays 
In all the Đases, tissues oƌ Đells ǁeƌe ĐolleĐted iŶ ‘NA lateƌ aŶd fƌozeŶ at −ϮϬ °C. EǆpƌessioŶ of 
several genes was evaluated in each case by Q-PCR assays performed as previously described 
(Martín-Ibáñez et al., 2007), using the following qPCR gene expression assays: 
 To provide negative controls and exclude contamination by genomic DNA, the reverse transcriptase 
was omitted in the cDNA synthesis step, and the samples were subjected to the PCR reaction with 
each Takara gene expression assay. 
AŶalǇsis aŶd ƋuaŶtiﬁĐation was performed with the Comparative Quantitation Analysis program of 
the MǆPƌo™ Q-PCR analysis software version 3.0 (Stratagene, La Jolla, CA, USA), using the 18S gene 
expression as internal loading control. All Q-PCR assays were performed in duplicate. The results are 
expressed as the log transformed relative levels with respect to the expression of the same gene in 
the control condition: 
- 4–5 wpc samples in the analysis of Nestin expression in primary brain fetal tissue 
- 4 wpc in the analysis of gene expression in primary forebrain samples at different 
developmental stages and 
- Passage 0 in the analysis of expression along passages 3 and 6 for cortical and WGE samples, 
considered as 1. 
Ϯ.ϭϰ. QuaŶtiﬁĐatioŶ aŶd statistiĐal aŶalǇsis 
For the cell density Assay see Section 2.7. 
For the mechanical versus enzymatic dissociation study see Section 2.8. 
The analysis of the % of cell death or viability was performed for primary brain fetal human tissue 
obtained from different developmental stages (4–5, 6–7and 8–9 wpc) and brain regions (Forebrain, 
Cortex, WGE and Cerebellum). In addition, Passage 1 neurospheres derived from these three 
developmental stages were also analyzed for this parameter. Results were expressed as individual 
values (4–8 samples) and the mean. Statistical analysis was performed by one way ANOVA and 
Tukey's multiple comparison test. The percentage of cell death was also analyzed along passages for: 
different developmental stages (4–5, 6–7and8–9 wpc) and brain regions (Forebrain, Cortex, WGE 
and Cerebellum). Results were expressed as the mean ± SEM of 3–11 hfNSC independent cultures. 
Statistical analysis was performed by two way ANOVA and Tukey's multiple comparison test. 
The expansion potential was analyzed by two parameters: ratio of proliferation and number of 
accumulated cells. The ratio of proliferation was compared between hfNSC obtained from different 
developmental stages (4–5, 6–7 and 8–9 wpc) at passage 1. Results were expressed as individual 
values (4–11 samples) and the mean. Statistical analysis was performed by one way ANOVA and 
Tukey's multiple comparison test. A comparative study was also done between the log transformed 
ratios of proliferation along passages for: different developmental stages (4–5, 6–7 and 8–9 wpc) 
and brain regions (Forebrain, Cortex, WGE and CB). Results were expressed as the mean ± SEM of 3–
11 hfNSC independent cultures. Statistical analysis was performed be-tween passages for each 
developmental stage or brain regions and be-tween developmental stages or brain regions for each 
passage. Two way ANOVA and Tukey's multiple comparison test was applied. 
The number of accumulated cells was calculated along 6 passages for different developmental 
stages (4–5, 6–7 and 8–9 wpc) and brain regions (Forebrain, Cortex, WGE and CB). Results were 
expressed as the square root transformed mean ± SEM of 4–10 hfNSC independent cultures. 
Statistical analysis was done comparing the square root trans-formed numbers of accumulated cells 
at each passage for each developmental stage or brain region in order to know how many pas-sages 
ǁeƌe ŶeĐessaƌǇ to eǆpaŶd the Đells sigŶiﬁĐaŶtlǇ. Tǁo ǁaǇ ANOVA aŶd TukeǇ's ŵultiple ĐoŵpaƌisoŶ 
test was applied. In addition, a comparison between developmental stages and brain regions was 
done for each passage. Two way ANOVA and Tukey's multiple comparison test was applied. 
Gene expression was studied for different experiments: 
a) Nestin mRNA levels in primary samples derived from fetal brain samples at three 
developmental stages: 4–5, 6–7and8–9wpc. 
b) Neurogenic and neuronal markers in primary samples derived from forebrain tissue at three 
developmental stages (5, 6 and 7 wpc). 
c) ChaŶges iŶ geŶe eǆpƌessioŶ pƌoﬁles iŶ Ŷeuƌospheƌes aloŶg passages PϬ, Pϯ aŶd Pϲ deƌiǀed 
from Cortical and WGE fetal samples. 
Results represent the mean of log transformed values ± SEM of 4–6 independent samples (except for 
forebrain samples that only 1–2sam-ples were used for each developmental stage). The results are 
expressed relative to 4–5 wpc (a), 4 wpc (b) and P0 (c), considered as 0. Statistical analysis was 
performed by one way ANOVA (a) or two way ANOVA (c) and Tukey's multiple comparison test. 
Differentiation analysis was performed along passages for WGE and Cortical cultures regardless of 
the developmental stage of derivation. Cultures were allowed to differentiate for 7 days at each 
passage as previously described and the percentages of Nestin, Ki67, b-III-tubulin and GFAP were 
ƋuaŶtiﬁed. ‘esults ǁeƌe eǆpressed as the percentage of positive cells for each staining with respect 
to the total number of cells. The average of data obtained from three to seven independent cultures 
for each brain region was calculated. Statistical analysis was performed by two way ANOVA and 
Tukey's multiple comparison test. 
3. Results 
3.1. Changes in the proliferative and post-mitotic populations along human fetal brain development 
determines the sensitivity of the tissue to the dissociation process 
The limited availability of human fetal brain samples has meant that most reports in the literature 
are derived from one developmental age or from pooled samples of different ages. In the present 
study we characterized the differences between human fetal brain regions obtained at three 
developmental intervals: 4–5, 6–7and 8–9 wpc (see Supplemetary Fig. 1 and Table 1). Primary fetal 
tissue was dissociated into single cells and viability was analyzed before plating the cells in 
suspension cultures for expansion (see scheme of the procedure in Fig. 1A). The comparative 
analysis of samples obtained from different developmental stages, independently of the brain region 
of origin, showed that primary human fetal brain cells from 4 to 5 wpc presented a higher 
percentage of viability than 6–7 and 8–9 wpc cells. However, no differences were ob-served 
between the viability of primary brain cells derived from 6 to 7 and from 8 to 9 wpc embryos (% of 
viability: 87,26 ± 3,18 for 4–5 wpc, 60,08 ± 4,34 for 6–7 wpc and 63,49 ± 7,53 for 8–9wpc;Fig. 1B). 
These results suggested that fetal human brain cells derived from younger developmental stages 
were more resistant to the dissection and dissociation process than the ones obtained from older 
embryos. qPCR of the NSC marker Nestin showed that brain fetal human samples derived from 4 to 
5 wpc embryos presented higher levels of Nestin expression than the ones obtained from 6 to 7 and 
from 8 to 9 wpc embryos (Fig. 1C). Interestingly, the expressioŶ of the ŶeuƌoŶal ŵaƌkeƌs β-III-
tubulin, Enkephalin, Substance P, Calbindin and vesicular glutamate transporter 1 showed an 
increase with later stages of forebrain development (Fig. 1D). In addition, the levels of expression of 
speĐiﬁĐ tƌaŶsĐƌiption factors involved in telencephalic development such as Ikaros, Helios, Tbr1, 
Stab1, Fez2, Ctip2 and Foxp1 also increased in samples de-rived from later stage forebra Results 
represent the mean of log transformed values ± SEM of 4–6 independent samples (except for 
forebrain samples that only 1–2sam-ples were used for each developmental stage). The results are 
expressed relative to 4–5 wpc (a), 4 wpc (b) and P0 (c), considered as 0. Statistical analysis was 
performed by one way ANOVA (a) or two way ANOVA (c) and Tukey's multiple comparison test. 
Differentiation analysis was performed along passages for WGE and Cortical cultures regardless of 
the developmental stage of derivation. Cultures were allowed to differentiate for 7 days at each 
passage as previously described and the percentages of Nestin, Ki67, b-III-tubulin and GFAP were 
ƋuaŶtiﬁed. ‘esults ǁeƌe eǆpressed as the percentage of positive cells for each staining with respect 
to the total number of cells. The average of data obtained from three to seven independent cultures 
for each brain region was calculated. Statistical analysis was performed by two way ANOVA and 
Tukey's multiple comparison test. 
3. Results 
3.1. Changes in the proliferative and post-mitotic populations along human fetal brain development 
determines the sensitivity of the tissue to the dissociation process 
The limited availability of human fetal brain samples has meant that most reports in the literature 
are derived from one developmental age or from pooled samples of different ages. In the present 
study we characterized the differences between human fetal brain regions obtained at three 
developmental intervals: 4–5, 6–7and 8–9 wpc (see Supplementary Fig. 1 and Table 1). Primary fetal 
tissue was dissociated into single cells and viability was analyzed before plating the cells in 
suspensionins (6 and 7 wpc; Fig. 1E). 
In order to corroborate these results, we next characterized by immunohistochemistry the presence 
and distribution of proliferative neural precursors and post-mitotic neurons in human fetal 
forebrains obtained from different developmental stages (Fig. 2). We observed that human embryos 
from 5 wpc presented more extensive positive areas for Nestin and Ki67, both in the cortical and the 
lateral ganglionic eminence (LGE), compared to the embryos analyzed at 10 wpc (Fig. 2A–F). Note 
that at 5 wpc the whole forebrain showed cells positive for Nestin and Ki67 (Fig. 2A–C), while these 
proliferative cells were restrict-ed to the germinal zone (GZ) adjacent to the ventricle at 10 wpc (Fig. 
2D–F). The analysis of neuronal markers showed that Doublecortin (DCX), a marker of newly 
generated neurons, was emerging in the mantle zone (MZ) and cortical plate (CP) of the LGE and the 
cortex, respectively, at 5 wpc. Some NeuN positive staining was observed in the same areas, albeit 
less extensive, indicating that few mature neurons had been generated by this early stage (Fig. 2G–
I). An increase in the expression of these two neuronal markers was observed at 8 wpc (Fig. 2J–L). 
Note that the expression of DCX was spread along the whole post-mitotic areas while NeuN positive 
Đells ǁeƌe positioŶed iŶ speĐiﬁĐ aƌeas of the Đaudate-putamen and cortex. In the former, NeuN 
positive cells were localized in the most lateral part of the caudal putamen (Fig. 2J–L). However, in 
the Đoƌteǆ, tǁo NeuN positiǀe aƌeas Đould ďe ideŶtiﬁed: oŶe iŶ the CP, the outeƌ ŵost laǇeƌ, aŶd a 
second one in the subventricular zone (Fig. 2J–L). Next, we analyzed the expression of Ctip2, a 
transcription factor involved in the neurogenesis of both the striatum and the cortex. Ctip2 
expression was restricted to the subventricular zone and small neurogenic areas at 5 wpc (Fig. 2M–
O). However, at 10 wpc it was spread through the caudate and putamen, and the intermediate zone, 
the subplate and the plate in the cortex (Fig. 2P–R). 
3.2. The expansion potential of human fetal ďrain neurospheres is not inﬂuenced by the 
developmental stage of derivation 
Dissociated cells derived from human fetal brain samples at different developmental stages were 
grown in suspension to form so-called neurospheres and were propagated over 6 passages, with 
analysis of cell survival and proliferation ratio at each passage. Primary neurospheres derived from 8 
to 9 wpc fetal brain tissue presented a higher percentage of cell death than the ones obtained from 
4 to 5 and from 6 to 7 wpc embryos (Fig. 3A). In addition, primary neurospheres derived from 4 to 5 
wpc embryos presented higher proliferation ratios than the ones derived from older embryos (6–7 
and 8–9 wpc; Fig. 3B). Note that the ratios of proliferation were very low in all cases (2.92 ± 1.32 for 
4–5wpc,0.70±0.17for6–7wpcand 0.96 ± 0.22 for 8–9 wpc) pointing to a very low expansion rate 
ďefoƌe the ﬁƌst passage. 
 
 
 
 
 
 
 
 
  
 
Fig. 1. Primary brain human fetal samples derived from earlier developmental stages are less sensitive to the dissection and 
dissociation process. A) Schematic representation of the protocol followed for human fetal brain samples characterization. 
B) Cell death percentage after dissociation of human fetal brain primary samples from different developmental stages: 4–5, 
6–7and8–9 wpc. Data are expressed as individual values and mean of 4–5 human brain fetal primary samples. Statistical 
analysis is performed by one way ANOVA and Tukey's multiple comparison test. *p b 0.05, **p b 0.005. C) RT-PCR analysis 
of Nestin mRNA levels of expression in human fetal brain primary samples derived from different developmental stages: 4–
5, 6–7and 8–9 wpc. Results represent the mean ± SEM of 4–5 independent samples and are expressed relative to 4–5 wpc 
derived samples, considered as 1. Statistical analysis is performed by one way ANOVA and Tukey's multiple comparison test 
*p b 0.05. D–E) Q-PCR analysis of the mRNA levels of expressioŶ of speĐiﬁĐ genes implicated in differentiation performed in 
forebrain primary human fetal samples obtained at 4, 6 and 7 wpc. Results represent the levels of expression of 1–2 
samples and are expressed relative to 4 wpc derived samples, considered as 1. 
Neǆt, ǁe studied ǁhetheƌ ŵodiﬁĐatioŶs iŶ the iŶitial Đell deŶsitǇ ŵight ďe deteƌŵiŶaŶt to iŵpƌoǀe 
cell survival and proliferation. With this aim we cultured 6–7and 8–9 wpc primary human fetal brain 
cells at different densities ranging from 20.000–160.000 cells/cm2 (Fig. 3C–D) in suspension cultures. 
After 10 days, we did not ob-serve differences in the viability, nor in the ratio of proliferation 
between the cells densities studied for 6–7and 8–9 wpc derived cultures (Fig. 3C, D). 
Taking into account the lack of differences between cell densities, we used the intermediate one 
(80.000 cells/cm2)to perform the expansion experiments. First, we analyzed if the differences found 
between develop-mental stages for the cell survival in primary neurospheres (P1) were maintained 
along the 5 following passages (Fig. 3E–FͿ. ‘esults shoǁed that afteƌ the ﬁƌst passage Ŷo diffeƌeŶĐes 
were observed between cultures (Fig. 3E). The study of the expansion potential along passages 
demonstrated differences in the proliferation ratios at passage 2 between 4–5 and 8–9 wpc derived 
cultures (Fig. 3F).However, from passage 3onwards a lack of differences between developmental 
stages were found neither in the proliferation ratios nor in the number of accumulated cells (Fig. 3F 
and Supplementary Fig. 2, respectively). Note that during the initial 3 pas-sages the percentages of 
cell death and the proliferation ratios were very variable for all the cultures. However, after the 
fourth passage the viability is stabilized between 70 and 80% and the mean proliferation rates in-
creased above 2 (log transformed proliferation ratio above 0.3; Fig. 3E–F). These results point to the 
adaptation and/or stabilization of the hfNSC cultures after passaging. Accordingly, accumulated cell 
curves showed that Đultuƌes staƌted to eǆpaŶd sigŶiﬁĐaŶtlǇ afteƌ ϲ passages foƌ the thƌee 
developmental stages under study (Supplementary Fig. 2). 
3.3. Mechanical versus enzymatic dissociation: a key step in the expansion of hfNSCs 
A general feature observed for the hfNSC neurosphere cultures was the low rates of proliferation 
over the passages studied. In order to study whether the mechanical dissociation could improve 
expansion rates, we compared enzymatic versus mechanic dissociation. Enzymatic dissociation of 
neurospheres was undertaken using accutase since it achieves higher viabilities and faster post 
dissociation recovery than trypsin, which is more prone to causing cell death and membrane 
disruption (Wachs et al., 2003). Mechanical dissociation was achieved by manually cutting the 
spheres into small pieces (chopping). The same cultures were passaged over 6 passages using these 
two techniques, and the expansion ratio and the survival after passaging were analyzed (Fig. 4). Our 
results showed that the fold change in the number of cells with respect to the initial number plated 
ǁas sigŶiﬁcantly higher using the mechanic compared to the enzymatic dissociation after 3 and 6 
passages (Fig. 4A). The number of accumulated cells was also higher in the chopped cultures 
compared to the enzymatically dissociated ones but only at passage 6 (Fig. 4B). However, the 
peƌĐeŶtage of Đell death at passage ϲ ǁas sigŶiﬁĐaŶtlǇ higher for the mechanically-passaged cultures 
compared to the enzymatic dissociated ones (Fig. 4C). This result could be explained by the 
diffeƌeŶĐe iŶ the size of the spheƌes at the tiŵe of passage, ǁhiĐh ǁeƌe sigŶiﬁĐaŶtlǇ laƌgeƌ iŶ the Pϲ 
mechanic dissociated cultures compared to the enzymatic dissociated ones (data not shown). 
Interestingly, we also observed differences between passage 3 and 6 in the fold change and number 
of accumulated cells for both enzymatic and mechanically-passaged cultures. Thus, after 6 passages 
cultures dissociated using both techŶiƋues eǆpaŶded sigŶiﬁĐaŶtlǇ ŵoƌe thaŶ at passage ϯ, eǀeŶ 
though the survival of passage 6 mechanic dissociated cultures is lower than at passage 3 (Fig. 4A–
C). 
 
  
Fig. 2. Post-mitotic and neurogenic areas are observed in older fetal brain samples. A–R. Immunohistochemical 
characterization of human fetal coronal brain samples at 5, 8 and 10 wpc. A–F) Representative images of the neural stem 
cell markers Nestin and Ki67 at 5 wpc (A–C) and 10 wpc forebrains (D–F). G–L) The neuronal markers DCX and NeuN are 
mainly observed at the emerging mantel zone of the LGE and CP of the Ctx at 5 wpc (G–I). In contrast, they are extensively 
expressed at 10 wpc (J–L). M–R) Ctip2 positive cells are starting to emerge in 5 wpc human fetal brains (M–O), while they 
are spread through the intermediate zone, sub-plate and CP in the Ctx and caudate-putamen at 10 wpc (P–R). Ctx, cortex; 
LGE, lateral ganglionic eminence; MZ, mantel zone; GZ, germinal zone; VZ, ventricular zone; SVZ, subventricular zone; IZ, 
intermediate zone; SP, sub-plate; CP, cortical plate; Ca, caudate; Pu, putamen; ic, iŶterŵediate Đapsule. SĐale ďar: ϱϬϬ μŵ. 
 Fig. 3. Human fetal neural stem cell cultures stabilize after several passages independently of the developmental stage of 
origin. A–B) Percentage of cell death (A) and ratio of proliferation (B) of hfNSC derived from different developmental stages 
(4–5, 6–7and8–9 wpc) and cultured for 1 passage. Data are expressed as individual values and mean of 4–11 human brain 
fetal primary samples. Statistical analysis was performed by one way ANOVA and Tukey's multiple comparison test. *p b 
0.05, ** b 0.005. C-D) Study of the effect of the plating cell density in the survival (C) and proliferation ratios (D) of hfNSC 
cultures derived from 6 to 7 and from 8 to 9 wpc embryos. Results are expressed as the mean ± SEM of 3–5 hfNSC 
independent cultures. Statistical analysis was performed by two way ANOVA and Tukey's multiple comparison test for the 
comparison of cell densities for each developmental stage. E–F) Study of the percentage of cell death (E) and log 
transformed proliferation ratios (F) along passages for each developmental stage under study (4–5, 6–7and 8–9 wpc). 
Results are expressed as the mean ± SEM of 3–11 hfNSC independent cultures. Statistical analysis was performed by two 
way ANOVA and Tukey's multiple comparison test **p b 0.005 and *p b 0.05 for 4–5 wpc respect to 8–9wpc cultures and 
&&&p b 0.005 for 4–5 wpc respect to 6–7 wpc and $p b 0.05 for 6–7 wpc respect to 8–9 wpc cultures. 
 
ϯ.ϰ. The eǆpansion potential of hfNSC is inﬂuenĐed ďǇ their ďrain region of origin 
In order to study different brain sources of hfNSC for their potential use in cell therapy for HD we 
dissected out: WGE, cortex, cerebellum and forebrain (Table 1). Of note, MTOP permitted precise 
dissection of the regions of interest since this methodology provided us with intact whole brain. 
No differences were found between brain areas in the survival of the primary tissue after 
dissociation (Supplementary Fig. 3). At 7 days most of the cultures formed neurospheres 
independently of the brain region of origin. Neurosphere number and growth rate was similar for 
fore-brain, WGE and cortical derived cultures, but cerebellum-derived neurospheres were the 
smallest as well as the lowest in number com-pared to the rest of brain regions at P0 (see a 
representative picture in Fig. 5A). 
We next analyzed the phenotype and distribution of the neurospheres forming cells at 10 days after 
passage 1 using immunocytochemistry (see a representative picture in Fig. 5B). Nearly all the cells 
within the sphere were Nestin positive for all the brain regions studied and the distribution was 
homogeneous. We also observed positive cells for the proliferation marker Ki67, which were 
distributed throughout the neurosphere without differences between the four regions studied. 
Interestingly, in all the neurospheres examined, very few cells expressed the astrocyte-speĐiﬁĐ 
marker GFAP and the neuron-speĐiﬁĐ ŵaƌkeƌ β-III-tubulin (Fig. 5B). 
Next, we analyzed the expansion potential of hfNSCs derived from these four brain regions over 6 
passages. For that, we studied cell survival, proliferation ratios, and number of accumulated cells 
(Supplementary Fig. 4 and Fig. 5C–D). Regardless of the brain areas of origin there was a substantial 
variability in the viability and the proliferation ratios during the initial 3 to 4 passages for all the 
cultures (Supplementary Fig. 4 and Fig. 5C). Nevertheless, after 4 passages they all stabilized with 
cell death values below 41% at passage 6 (% cell death at passage 6: fore-brain: 33.57 ± 7.28; WGE: 
29.91 ± 3.63; Cortex: 23.94 ± 3.28 and Cerebellum: 29.91 ± 6.48). In addition, the proliferation ratios 
reached mean values of 2–3, except for cerebellar derived cultures, which reached mean ratios 
below 2 (proliferation ratios at passage 6: fore-brain: 2.34 ± 0.28; WGE: 3.39 ± 0.68; Cortex: 2.62 ± 
0.48 and Cerebellum 1.73 ± 1.08; Fig. 5C shows log transformed values). No differences were found 
between the proliferation ratios at different passages for each brain region studied. However, 
sigŶiﬁĐaŶt diffeƌeŶĐes ǁeƌe observed between WGE and Cortex derived cultures at passage 2 and 
between Forebrain, WGE and Cortex respect to Cerebellar derived cultures at passage 4 (Fig. 5C). 
 
  
Fig. 4. Effect of the splitting methodology on the expansion of neurosphere cultures derived from hfNSC. A–C) Expansion of 
neurospheres cultures is analyzed using two different dissociation techniques: mechanic (chopping) versus enzymatic (using 
accutase). A) Log transformed fold change in the number of cells at passage 3 (P3) and 6 (P6). Results are expressed 
individual values and the mean. Statistical analysis was performed by one way ANOVA and Tukey's multiple comparison 
test. ***p b 0.002 and ****p b 0.0001. B) Square root transformed number of accumulated cells for mechanically and 
enzymatic dissociated spheres at P3 and P6. Results are expressed as individual values and the mean. Statistical analysis 
was performed by one way ANOVA and Tukey's multiple comparison test. ***p b 0.002 and ****p b 0.0001. sqrt: square 
root transformed. C) Percentage of cell death after splitting mechanically or enzymatically at P3 and P6. Results are 
expressed as individual values and the mean. Statistical analysis was performed by one way ANOVA and Tukey's multiple 
comparison test. **p b 0.005. sqrt: square root transformed. 
 Fig. 5. Neurospheres derived from several human fetal brain regions present differences in the expansion potential. A–D) 
Characterization of hfNSCs derived from several brain regions: Forebrain, Cortex, WGE and Cerebellum. A) Primary cells 
derived from all four regions are able to form spheres in suspension cultures. B) Representative pictures of 
immunocytochemistry for the neural marker Nestin, the proliferative marker Ki67, the astrocytic marker GFAP and the 
ŶeuroŶal ŵarker β-III-tubulin in forebrain derived spheres at passage 3. C) Log transformed proliferation ratios of cultures 
derived from the different brain regions under study through 6 passages. Results are expressed as the mean ± SEM. 
StatistiĐal aŶalǇsis ǁas perforŵed ďǇ tǁo ǁaǇ ANOVA aŶd TukeǇ's ŵultiple ĐoŵparisoŶs test. δp ď Ϭ.Ϭϱ, **p ď Ϭ.ϬϬϱ &&&p 
ď Ϭ.ϬϬϮ aŶd $$$$p ď Ϭ.ϬϬϬϭ ;δWGE respeĐt to Ctǆ Đultures. *ForeďraiŶ respeĐt to CB Đultures. &Ctǆ respect to CB cultures 
and $WGE respect to CB cultures. D) Representation of the square root transformed number of accumulated cells for 
cultures expanded from Forebrain, WGE, Ctx and CB. Results are expressed as the mean ± SEM. Statistical analysis is 
performed by two way ANOVA and Tukey's multiple comparison test. $$p b 0.005, ***,&&&p b 0.002 and ****p b 0.0001 
(*Forebrain respect to CB cultures, $WGE respect to CB cultures, &Ctx respect to CB cultures). The comparison between 
passages of the sqrt number of accumulated cells for each brain region shows: forebrain ***p b 0.002 P5 respect P1, **p b 
0.005 P5 respect P2 and *p b 0.05 P5 respect P3. ****p b 0.0001 P6 respect P1, P2 and P3 and ***p b 0.002 P6 respect P4. 
WGE: *** p b 0.002 P6 respect P1, P2 and P3 and **P b 0.005 P6 respect P4. Cortex: ****p b 0.0001 P6 respect P1, P2 and 
P3 and ***p b 0.002 P6 respect P4. WGE: whole ganglionic eminence; CB: cerebellum, Ctx: cortex. sqrt: square root 
traŶsforŵed. SĐale ďar: Ϯϱ μŵfor ;BͿ. 
The analysis of the proliferation curves, where the number of accumulated cells after sequential 
passaging is represented, showed that forebrain-deƌiǀed NSCs ǁeƌe eǆpaŶdiŶg sigŶiﬁĐaŶtlǇ ŵoƌe 
than Cerebellar ones at passage 5 and 6 (Fig. 5D). In addition, WGE and Cortical-derived NSC 
expanded more than Cerebellar ones only at passage 6 (Fig. 5D). No differences were found in the 
expansion potential of Fore-brain, Cortex and WGE derived cultures along passages. However, fore-
brain-deƌiǀed NSC ǁeƌe fouŶd to eǆpaŶd sigŶiﬁĐaŶtlǇ afteƌ ϰ passages (passage 5 respect P1–P3 and 
passage 6 respect to P1–P4) whereas cortiĐal aŶd WGE deƌiǀed Đultuƌes ǁeƌe sigŶiﬁĐaŶtlǇ eǆpaŶded 
at passage 6 (respect to P1–P5). In contrast, cerebellar derived hfNSCs were not able to expand even 
after 6 passages. All these results suggest that intrinsic differences exist in the expansion potential of 
hfNSC derived from several brain regions. 
3.5. Region-speĐiﬁĐ gene eǆpression proﬁles were partiallǇ lost for ĐortiĐal hfNSCs after eǆpansion 
To determine whether human fetal neurospheres derived from different brain regions retain their 
regional identities over passages, ǁe aŶalǇzed geŶe eǆpƌessioŶ pƌoﬁles at passage Ϭ, ϯ aŶd ϲ. Foƌ 
this experiment we studied cortical and WGE-derived cultures. The analysis of early neural molecular 
markers showed that WGE derived cultures maintained the expression of Sox2 with sequential 
passages. This ǁas also the Đase foƌ speĐiﬁĐ ƌegioŶal geŶes suĐh as Dlǆϭ, Ϯ aŶd ϱ, GsǆϮ ;GshϮͿaŶd 
Ascl1 (Mash1). However, Foxg1 was down-regulated at 6 (Fig. 6A). Nolz1, Helios, Ikaros, Nkx2.1, 
Foǆpϭ aŶd CtipϮ ǁeƌe aŶalǇzed as speĐiﬁĐ tƌaŶsĐƌiption factors involved in the generation of post-
mitotic neurons in the WGE. All these molecular markers were down regulated after 6 sequential 
passages, except foƌ Helios, ǁhiĐh eǆpƌessioŶ ǁas Ŷot ŵodiﬁed ;Fig. ϲBͿ. Ouƌ ƌesults also shoǁed 
that WGE derived neurosphere cultures presented very low levels of expression of cortical Pax6, 
NgŶϮ aŶd Đeƌeďellaƌ GďǆϮ ƌegioŶ speĐiﬁĐ geŶes that ǁeƌe Ŷot ŵodulated afteƌ seƋueŶtial passaging 
(Fig. 6C). 
In contrast, cortical derived cultures behaved differently. Sox2, Foxg1 and Pax6 expression were not 
ŵodiﬁed ǁith passages. IŶ additioŶ, ŵost ĐoƌtiĐal speĐiﬁĐ eaƌlǇ Ŷeuƌal geŶes suĐh as NgŶϭ, Ϯ, Eŵǆϭ 
and Tbr2 were down regulated at passage ϯ aŶd ϲ ;Fig. ϲDͿ, as ǁeƌe the ĐoƌtiĐal speĐiﬁĐ neuronal 
markers(Tbr1, Cux2 and Fezp2) that we analyzed (Fig. 6E). When we examined WGE neural genes - 
Dlx2 and Gsx2 (Gsh2) - in cortical-derived hfNSCs, we obseƌǀed that these geŶes ǁeƌe sigŶiﬁĐaŶtly 
up-regulated after 3 and 6passages(Fig. 6F). However, no changes were observed for Ascl1 (Mash1) 
and Gbx2 that were expressed at very low levels in cortical samples (Fig. 6F). 
 Fig. 6. Gene expression analysis of WGE and Cortical derived cultures along passages. RT-PCR analysis of gene expression 
proﬁles aloŶg passages ;PϬ, Pϯ aŶd PϲͿ of WGE aŶd CortiĐal deriǀed Đultures. Three Đategories are studied: earlǇ Ŷeural 
precursor's genes (A–D), mature neuronal genes (B–EͿ ďoth speĐiﬁĐ for eaĐh ďraiŶ area aŶd other brain regions genes (C–F). 
Results represent the log transformed mean ± SEM of 4–5 independent samples and are expressed relative to P0, 
considered as 0. Statistical analysis is performed by two way ANOVA and Tukey's multiple comparison test. *p b 0.05, 
**,$$p b 0.005, ***p b 0.002,****,$$$$p b 0.0001 (*Passage 6 respect to Passage 0 and $Passage 6 respect to Passage 3). 
P: passage. 
 
3.6. WGE and cortical derived neurosphere cultures maintained their differentiation potential after 
sequential passaging 
It has been previously described that neurosphere cultures reduce their neurogenic differentiation 
potential along passages with increase in gliotic potential. Thus, we next evaluated the 
differentiation potential of WGE and cortical derived neurospheres cultures across passages. Single 
cell suspensions at different passages (P1–P6) were plated, and after seven days neural 
diffeƌeŶtiatioŶ ǁas eǀaluated. QuaŶtiﬁĐatioŶ of the differentiated phenotypes showed that the 
number of Nestin positive cells was between 35 and 60% for both cortical and WGE (Fig. 7A, C, G, I). 
These results indicated that a high percentage of cells was not completely differentiated after 7 
days.  
 Fig. 7. WGE and Cortical cultures remain multipotent after 6 passages. A–L) Quantitative analysis of the percentages of 
NestiŶ, Kiϲϳ, GFAP aŶd β-III-tubulin along passages for WGE and Cortical derived cultures. Representative pictures for 
NestiŶ ;AͿ aŶd Kiϲϳ ;BͿ, β-III-tubulin (D) and GFAP (E) positive cells after 7 days of differentiation for cortical cultures at 
Passage ϭ. RepreseŶtatiǀe piĐtures for NestiŶ ;GͿ aŶd Kiϲϳ ;HͿ, β-III-tubulin (J) and GFAP (K) positive cells after 7 days of 
differentiation for WGE cultures at Passage 1. Results represent the mean ± SEM of 4–5 independent samples. Statistical 
aŶalǇsis ǁas perforŵed ďǇ tǁo ǁaǇ ANOVA aŶd TukeǇ's ŵultiple ĐoŵparisoŶ test. SĐale ďars: ϱϬ μŵ. 
However, not all the Nestin positive cells were immunoreactive for Ki67 since the percentages of this 
proliferative marker (between 9 and 46%) were lower than the percent-ages of Nestin (Fig. 7B, C, H, 
IͿ. These ﬁŶdiŶgs iŶdiĐated that soŵe NestiŶ positiǀe pƌeĐuƌsoƌs ǁeƌe out of the Đell ĐǇĐle aŶd 
therefore, committed at the time of analysis. We next analyzed the number of neurons and as-
trocytes after diffeƌeŶtiatioŶ. The ŵeaŶ ǀalues foƌ β-III-tubulin positive neurons, were around 15–
38% for cortical and WGE cultures. In addition, the mean values for the percentage of astrocytes, 
immunoreactive for GFAP, were found to be around 5–35% (Fig. 7D–F, J–L). No differences were 
fouŶd ďetǁeeŶ passages iŶ the peƌĐeŶtages of aŶǇ of the ŵaƌkeƌs studied ;NestiŶ, Kiϲϳ, β-III-tubulin 
and GFAP), neither for cortical nor for WGE cultures. In addition, no differences were found between 
cortical and WGE cultures in the percentages of all these markers. The potential to differentiate to 
oligodendrocytes was also evaluated by the analysis of O4 immunoreactivity, which was detected in 
very few cells for cultures derived from both brain areas (b1%. Data not shown). Thus, neurosphere 
cultures derived from both the WGE and the cortex remained multipotent during 6 passages, being 
able to differentiate mainly into neurons and astrocytes and to a lesser extent to oligodendrocytes. 
Next, we characterized the potential of neurospheres to give rise to different mature neuronal types 
after 6 passages. With this aim, P6 neurospheres were allowed to differentiate for 21 days and 
various neuronal markers were analyzed (Fig. 8). WGE and cortical differentiated cultures gave rise 
to a high percentage of MAP2 mature neurons (Fig. 8A), although the phenotypes of these neurons 
were slightly different. While WGE cultures showed a predominantly neuronal phenotype positive 
for DARPP32, Calbindin and Ctip2 (Fig. 8B, C and D, respectively), cortical cultures were more prone 
to differentiate to Vglut1 positive neurons in agreement with their region of origin (Fig. 8F). Similar 
differentiation potential towards Calretinin positive neurons was observed in cortical and WGE 
cultures (Fig. 8E). Interestingly, both of them were also able to differentiate to Tyroxine Hydroxylase 
(TH) positive cells, al-though with a low incidence (Fig. 8G). 
 
Fig. 8. WGE and Cortical cultures keep the potential to differentiate to mature neuronal phenotypes after expansion. 
Immunocyto chemical analysis of WGE and Cortical cultures, 21 days after differentiation. Both WGE and Cortical cultures 
are able to differentiate to MAP-2 (A), DARPP-32 (B), Calbindin (C), Ctip2 (D), Calretinin (E),V-glut1(F)and Tyrosine 
Hydroxylase(G). Scale ďars: Ϯϱ μŵ. 
4. Discussion 
One of the challenges in the development of cell replacement therapies for neurodegenerative 
diseases is the ideŶtiﬁĐatioŶ aŶd full ĐhaƌaĐterization of easily expandable multipotent donor cell 
sources with the capacity to diffeƌeŶtiate iŶto the speĐiﬁĐ tǇpes of ŶeuƌoŶs lost to the dis-ease 
process. In the present work, we studied hfNSCs derived at different developmental stages from 
several brain areas as a source of renewable cells for clinical trials for HD. Our results show that the 
developmental stage of isolation is a critical factor for the capacity of primary cells to survive the 
dissection and dissociation process. As the brain develops neurogenesis takes place and the number 
of neural precursors is diminished while there are more post-mitotic neurons. Therefore, primary 
brain cells from older embryos present a higher sensitivity to the dissociation process and lower 
proliferation ratios. Nevertheless, the proliferation ratios were very low in all cases independently of 
the developmental stage. Improvements in the proliferation rates were obtained by dissociating the 
spheƌes ŵeĐhaŶiĐallǇ iŶstead of eŶzǇŵatiĐallǇ, ďut Ŷot ďǇ ŵodiﬁĐatioŶs iŶ the Đell deŶsitǇ. The 
comparison between spheres derived from several human fetal brain areas showed differences in 
the expansion potential, with forebrain, WGE and cortical derived cells being the most expandable. 
EǆpaŶsioŶ of hfNSC Đultuƌes paƌtiallǇ ŵodiﬁed the ƌegional identity of cortical cultures, and to a 
lesser extent WGE derived ones. Nevertheless, both cultures kept their potential to differentiate to 
neurons, astrocytes and oligodendrocytes after 6 passages, as well as the ability to differentiate to 
mature neuronal phenotypes. 
Clinical trials using primary human fetal brain tissue in HD involved the use of embryos from 
different developmental stages (6–12 wpc). However, the optimum gestational window for human 
donor fetal striatum has not yet been determined and little is known about the intrinsic differences 
between them. Our results show that the developmental stage of MTOP derivation is critical for the 
viability of the tissue after dis-section and dissociation. Although previous work reported higher 
viabilities for MTOP derived brain samples (Kelly et al., 2011), they included fewer samples from 
older embryos, which are the ones presenting lower viabilities (present results). Taking into account 
that the dissected tissue is composed of germinal zone containing neural precursors as well as their 
immediate progeny (neuronal, neuroglial, and glial progenitors) and newly post-mitotic cells (Maric 
and Barker, 2004; present results), we hypothesize that the decrease in viability and lower 
proliferation ratios observed for older derived samples might be due to the presence of a lower 
percentage of neural precursors that goes along with an increase in the number of post-mitotic 
neurons. This is in agreement with the enlargement of post-mitotic areas in the human fetal 
telencephalon observed at later developmental stages (8–11 wpc) (Onorati et al., 2014 and present 
results). These changes are ac-ĐoŵpaŶied ďǇ ŵodiﬁĐatioŶs iŶ the expression pattern of many 
transcription factors involved in neurogenesis such as: Nkx2.1, Ikaros, Tbr1, Ctip2, Foxp1 and Foxp2 
in accordance with our RT-PCR results (present results). 
Along the same lines, we postulate that neurospheres derived from older tissue might contain a 
higher percentage of post-mitotic cells than the younger ones, accounting for the lower proliferation 
ratio ob-served at P1. These post-mitotic cells might be decreasing over time in culture, as previously 
described (Sun et al., 2011). In agreement, we show that the levels of expression of post-mitotic 
neuronal genes de-crease after sequential passaging and the differences in the proliferation ratios 
disappear. These results indicate that the number of cells with neurosphere forming capacity might 
be similar between the develop-mental stages under study. Coincidentally, Piao and collaborators 
did not observe a correlation between the number of CD133 positive pro-genitors in P1 spheres and 
the developmental stage of forebrain spheres derivation (Piao et al., 2006). Moreover, our results 
also show that the developmental stage of derivation does not have any effect in the expansion 
potential along 6 passages. Thus, once the post-mitotic population is lost after initial passaging, the 
viability and the ratios of proliferation become stabilized and the Đultuƌes ƌeaĐh sigŶiﬁĐaŶt 
expansion rates at passage 6. However, it is worth noting that there is a huge variability in the 
expansion potential within cultures derived from the same gestational age in agreement with 
previous work (Piao et al., 2006). 
The eǆpaŶsioŶ poteŶtial oďseƌǀed iŶ the pƌeseŶt ǁoƌk is sigŶiﬁĐaŶt-ly lower than those described in 
previous publications (Kallur et al., 2006; Kim et al., 2006). Methodological differences in human 
fetal brain tissue procurement (STOP or MTOP), culture conditions, passaging methodology and 
frequency may explain them (Jensen and Parmar, 2006). In fact, different disaggregation 
methodologies have been previously used for human neurosphere passaging: mechanic and 
enzymatic (Fan et al., 2014; Hitoshi et al., 2002; Kim et al., 2006; Ribeiro et al., 2013; Zietlow et al., 
2005). Interestingly, our results demonstrate that mechanical disaggregation gave rise to higher 
proliferation ratios after 3 and 6 passages and therefore a higher expansion rate compared to 
eŶzǇŵatiĐ dissoĐiatioŶ. These ﬁŶdiŶgs aƌe iŶ agƌee-ŵeŶt ǁith a pƌeǀious ƌepoƌt that deﬁŶe 
mechanical disaggregation as the least aggressive method (Gil-Perotín et al., 2013). However, 
neurospheres expanded by mechanical passage are bigger after 6 pas-sages and a higher cell death 
after complete dissociation is also ob-seƌǀed. These ﬁŶdiŶgs Đould ďe eǆplaiŶed ďǇ the fact that the 
cells in the inner layers have less access to the culture medium and therefore the availability of 
oxygen and nutrients is considerably reduced (Bez et al., 2003). Increasing the frequency of passage 
aŶd ƌeﬁŶiŶg the ŵethodology are possible solutions to avoid neurosphere over-growth and improve 
hfNSC eǆpaŶsioŶ sigŶiﬁĐaŶtlǇ. 
In order to explore different fetal brain sources of expandable hfNSCs obtained by MTOP for HD cell 
replacement therapies we compared hfNSCs from developing WGE, cortex, forebrain and 
cerebellum. In agreement with previous work, cells derived from all the regions under study were 
able to grow in suspension forming spheres (Darsalia et al., 2007; Fan et al., 2014; Kallur et al., 2006; 
Kim et al., 2006; Zietlow et al., 2005). Regardless of the region of origin, neurospheres show a 
heterogeneous composition containing proliferating neural progenitor cells, neurons and glia (Fan et 
al., 2014; Jensen and Parmar, 2006; Kallur et al., 2006; Kim et al., 2006). Interestingly, although most 
of the cells within the neurospheres are positive for the neural stem cell marker Nestin (Kallur et al., 
2006; Kim et al., 2006), fewer cells are positive for the proliferative marker Ki67 (Jensen and Parmar, 
2006; Reynolds and Rietze, 2005; Reynolds and Weiss, 1996). In agreement, the proliferation ratios 
are very low for all the brain regions studied. These results point to the notion that a small percent-
age of cells holds neurosphere forming capacity. 
Besides the general low proliferation ratios, analysis of the expaŶsioŶ poteŶtial shoǁ sigŶiﬁĐaŶt 
differences depending on the region of origin. Rostral derived hfNSC cultures are more expandable 
than caudal derived ones in agreement with previous reports (Horiguchi et al., 2004; Kim et al., 
2006) and in this study forebrain, WGE and cortical derived hfNSC are the most expandable ones. 
Interestingly, no differences are found between the expansion potential of cortical and WGE derived 
samples as previously described (Kim et al., 2006). In our culture conditions cerebellar derived 
cultuƌes ǁeƌe Ŷot aďle to eǆpaŶd efﬁĐiently enough to increase the population through passages. 
This result might be due to the early stage of derivation (7–9 wpc) for this brain region. In fact, Fan Y 
and col-laborators described an increase in the NSCs iŶitiatiŶg ĐoloŶǇ efﬁciency for cerebellar 
deƌiǀed saŵples ǁith iŶĐƌeasiŶg gestatioŶ ďetǁeeŶ ϭϰ aŶd Ϯϯ ǁpĐ, oďtaiŶiŶg the highest efﬁĐieŶĐǇ 
at 23 wpc (Fan et al., 2014). 
Next, we studied the regional identity and differentiation potential of hfNSC through passaging for 
WGE and cortical derived samples. Sox2 is expressed early in neuroepithelial development, and its 
expression persists in both mitotically competent NSCs and their transit-amplifying daughters 
(Graham et al., 2003; Pevny and Placzek, 2005; Pevny and Nicolis, 2010; Zappone et al., 2000). In 
additioŶ, SoǆϮ eǆpƌessioŶ seleĐtiǀelǇ ideŶtiﬁed ŵultipoteŶtial aŶd self-renewing neural progenitor 
cells in dissociates of human fetal fore-brain (Wang et al., 2010). Taking into account these previous 
ƌesults, the pƌeseŶt ﬁŶdiŶgs iŶdiĐate that a SoǆϮ posgoes aloŶg ǁith aŶ iŶĐƌease iŶ the Ŷuŵďeƌ of 
post-mitotic neurons. This is in agreement with the enlargement of post-mitotic areas in the human 
fetal telencephalon observed at later developmental stages (8–11 wpc) (Onorati et al., 2014 and 
present results). These changes are ac-ĐoŵpaŶied ďǇ ŵodiﬁĐatioŶs iŶ the expression pattern of 
many transcription factors involved in neurogenesis such as: Nkx2.1, Ikaros, Tbr1, Ctip2, Foxp1 and 
Foxp2 in accordance with our RT-PCR results (present results). 
Along the same lines, we postulate that neurospheres derived from older tissue might contain a 
higher percentage of post-mitotic cells than the younger ones, accounting for the lower proliferation 
ratio ob-served at P1. These post-mitotic cells might be decreasing over time in culture, as previously 
described (Sun et al., 2011). In agreement, we show that the levels of expression of post-mitotic 
neuronal genes de-crease after sequential passaging and the differences in the proliferation ratios 
disappear. These results indicate that the number of cells with neurosphere forming capacity might 
be similar between the develop-mental stages under study. Coincidentally, Piao and collaborators 
did not observe a correlation between the number of CD133 positive pro-genitors in P1 spheres and 
the developmental stage of forebrain spheres derivation (Piao et al., 2006). Moreover, our results 
also show that the developmental stage of derivation does not have any effect in the expansion 
potential along 6 passages. Thus, once the post-mitotic population is lost after initial passaging, the 
viability and the ratios of proliferation become stabilized and the Đultuƌes ƌeaĐh sigŶiﬁĐaŶt 
expansion rates at passage 6. However, it is worth noting that there is a huge variability in the 
expansion potential within cultures derived from the same gestational age in agreement with 
previous work (Piao et al., 2006). 
The expansion potential observed in the present work is sigŶiﬁĐaŶt-ly lower than those described in 
previous publications (Kallur et al., 2006; Kim et al., 2006). Methodological differences in human 
fetal brain tissue procurement (STOP or MTOP), culture conditions, passaging methodology and 
frequency may explain them (Jensen and Parmar, 2006). In fact, different disaggregation 
methodologies have been previously used for human neurosphere passaging: mechanic and 
enzymatic (Fan et al., 2014; Hitoshi et al., 2002; Kim et al., 2006; Ribeiro et al., 2013; Zietlow et al., 
2005). Interestingly, our results demonstrate that mechanical disaggregation gave rise to higher 
proliferation ratios after 3 and 6 passages and therefore a higher expansion rate compared to 
eŶzǇŵatiĐ dissoĐiatioŶ. These ﬁŶdiŶgs aƌe iŶ agƌeemeŶt ǁith a pƌeǀious ƌepoƌt that deﬁŶe 
mechanical disaggregation as the least aggressive method (Gil-Perotín et al., 2013). However, 
neurospheres expanded by mechanical passage are bigger after 6 pas-sages and a higher cell death 
after complete dissociation is also ob-seƌǀed. These ﬁŶdiŶgs Đould ďe eǆplaiŶed ďǇ the faĐt that the 
cells in the inner layers have less access to the culture medium and therefore the availability of 
oxygen and nutrients is considerably reduced (Bez et al., 2003). Increasing the frequency of passage 
aŶd ƌeﬁŶiŶg the ŵethodology are possible solutions to avoid neurosphere over-growth and improve 
hfNSC eǆpaŶsioŶ sigŶiﬁĐaŶtlǇ. 
In order to explore different fetal brain sources of expandable hfNSCs obtained by MTOP for HD cell 
replacement therapies we compared hfNSCs from developing WGE, cortex, forebrain and 
cerebellum. In agreement with previous work, cells derived from all the regions under study were 
able to grow in suspension forming spheres (Darsalia et al., 2007; Fan et al., 2014; Kallur et al., 2006; 
Kim et al., 2006; Zietlow et al., 2005). Regardless of the region of origin, neurospheres show a 
heterogeneous composition containing proliferating neural progenitor cells, neurons and glia (Fan et 
al., 2014; Jensen and Parmar, 2006; Kallur et al., 2006; Kim et al., 2006). Interestingly, al-though 
most of the cells within the neurospheres are positive for the neural stem cell marker Nestin (Kallur 
et al., 2006; Kim et al., 2006), fewer cells are positive for the proliferative marker Ki67 (Jensen and 
Parmar, 2006; Reynolds and Rietze, 2005; Reynolds and Weiss, 1996). In agreement, the 
proliferation ratios are very low for all the brainitive population might be the one giving rise to self-
renewing neurospheres in WGE and cortical-derived samples. Moreover, these expanded 
neurosphere cultures remain multipotent over 6 passages. Despite these similarities, neurosphere 
expanded cultures derived from WGE and cortex behave differently in the maintenance of region 
identity. WGE ex-panded cultures keep their regional identity through the expression of early 
transcription factors involved in striatal fate determination such as Dlx family members, Gsx2 
(Gsh2)and Ascl1 (Mash1)(Anderson et al., 1997; Stenman et al., 2003; Toresson et al., 2000; Wang et 
al., 2009). In agreement, long-term differentiation gives rise to a high percentage of DARPP-32 and 
Ctip2 positive cells as well as Calbindin and Calretinin positive neurons. This is coincident with the 
main striatal neuronal populations that are medium-sized spiny neurons which are positive for 
DARPP-32 and/or Calbindin (Deacon et al., 1994; Olsson et al., 1998) and some striatal interneurons 
that express Calretinin (Kawaguchi et al., 1995). In agreement with Kallur et al. we also obtained a 
low number of glutamatergic neurons in WGE cultures. Although contamination of WGE samples 
with cortical tissue during dissection could not be completely ruled out, it might be possible that 
striatal expanded cells can differentiate into glutamatergic neurons in vitro in agreement with 
previous authors (Kallur et al., 2006). In contrast, cortical-derived hfNSCs down-regulate most of its 
region speĐiﬁĐ eaƌlǇ geŶes afteƌ eǆpaŶsion, acquiring a ventral identity as previously described 
(Hitoshi et al., 2002; Parmar et al., 2002). Long term differentiation of cortical-derived neurospheres 
geŶeƌate a suďstaŶtial populatioŶ of glutaŵateƌgiĐ ŶeuƌoŶs ;positiǀe foƌ ǀglutϭͿ aŶd a sigŶiﬁĐaŶt 
number of interneurons most of which are positive for Calretinin and a smaller number for 
Calbindin, which correlates with the main cortical neuronal populations (Jones, 1993). Thus, 
although there is a ventralization at the level of cortical progenitors, they keep the potential to 
acquire a cortical neuronal fate. We also obtain a small population of DARPP-32 and Ctip2 positive 
neurons when differentiating cortical-derived neurospheres (Deacon et al., 1994; Olsson et al., 
1998). Although these markers have been broadly considered specific of striatal medium-spiny 
neurons, Onorati and collaborators have recently described positive cells for these two markers 
during cortical development at 8–11 weeks (Onorati et al., 2014). 
5. Conclusions 
Our results show that MTOP derived human fetal forebrain, WGE and cortex from 4 to 10 wpc have 
potential to be used as a source of expandable hNSCs for cell therapy replacement. hfNSC cultures 
deƌiǀed fƌoŵ the thƌee ďƌaiŶ ƌegioŶs eǆpaŶd sigŶiﬁĐaŶtlǇ afteƌ ϲ passages ǁhile keepiŶg theiƌ 
neurogenic potential. However, from our studies, WGE derived hfNSCs present the best potential as 
a doŶoƌ Đell souƌĐe foƌ HD tƌeatŵeŶt siŶĐe theǇ deŵoŶstƌate the highest efﬁĐieŶĐǇ of diffeƌ-
entiation to mature striatal neurons through the maintenance of the regional identity after 
expansion. 
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